Live price temporarily unavailable.
Moderna (MRNA) is a Health Care company in the S&P 500. Latest news and coverage below.
About Moderna
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA (mRNA) to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
Recent News (6)
-
Jim Cramer Says “For the First Time in Ages, I Like Having a Position in Moderna” Jim Cramer Says “For the First Time in Ages, I Like Having a Position in Moderna”
-
Moderna Is Up More Than 70% in a Month After a 9-0 FDA Vote. Wall Street's Average Price Target Says It Should Fall 44%. What Gives? Moderna Is Up More Than 70% in a Month After a 9-0 FDA Vote. Wall Street's Average Price Target Says It Should Fall 44%. What Gives?
-
Thermo Fisher Scientific (TMO) Wins Arcturus mRNA Role, Is The Upside Already Priced In? Thermo Fisher Scientific (TMO) Wins Arcturus mRNA Role, Is The Upside Already Priced In? simplywall.st
-
Moderna vs. Recursion: Which Cutting-Edge Pharma Stock Is a Better Buy in 2026? Moderna vs. Recursion: Which Cutting-Edge Pharma Stock Is a Better Buy in 2026?
-
Tesla, Rivian, Strategy, Moderna, Sandisk, Blue Owl, and More Stocks That Explain Today’s Market Tesla, Rivian, Strategy, Moderna, Sandisk, Blue Owl, and More Stocks That Explain Today’s Market
-